Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands

Autor: Nienke J. Veldhuijzen, Chris J.L.M. Meijer, Henrica C.W. de Vet, Nicole J Polman, Leon F.A.G. Massuger, Folkert J. van Kemenade, Yanne de Haan, Johannes Berkhof, Daniëlle A M Heideman
Přispěvatelé: Pathology, Epidemiology and Data Science, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, APH - Methodology, AII - Infectious diseases
Rok vydání: 2019
Předmět:
Adult
medicine.medical_specialty
Epidemiology
media_common.quotation_subject
Population
Uterine Cervical Neoplasms
Shame
HIV Infections
01 natural sciences
Specimen Handling
03 medical and health sciences
0302 clinical medicine
All institutes and research themes of the Radboud University Medical Center
Surveys and Questionnaires
medicine
Humans
Sampling (medicine)
030212 general & internal medicine
0101 mathematics
education
Cervix
Early Detection of Cancer
Netherlands
media_common
Preventive healthcare
education.field_of_study
Cervical screening
Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17]
Primary Health Care
business.industry
Papillomavirus Infections
010102 general mathematics
Public Health
Environmental and Occupational Health
Patient Preference
Middle Aged
Patient Acceptance of Health Care
Uterine Cervical Dysplasia
Self Care
Hpv testing
medicine.anatomical_structure
Family medicine
Female
business
Self sampling
Zdroj: Preventive Medicine, 125, 5-11. Academic Press Inc.
Preventive Medicine, 125, 5-11
Polman, N J, de Haan, Y, Veldhuijzen, N J, Heideman, D A M, de Vet, H C W, Meijer, C J L M, Massuger, L F A G, van Kemenade, F J & Berkhof, J 2019, ' Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands ', Preventive Medicine, vol. 125, pp. 5-11 . https://doi.org/10.1016/j.ypmed.2019.04.025
Preventive Medicine, 125, pp. 5-11
Preventive Medicine, 125, 5-11. Academic Press
ISSN: 1096-0260
0091-7435
Popis: Several countries offer HPV self-sampling for screening non-attendees. It is assumed that screening attendees also prefer self-sampling to clinician-based sampling, however, little research has been conducted with respect to this. Women participating in the IMPROVE-study were randomised (1:1) to self- or clinician-collected HPV testing, and HPV-positive women were retested using the other collection method. Three different questionnaires were sent out among a subset of participating women: Q1) HPV-positive women from both study groups were asked about their experiences with self-sampling and clinician-based sampling (n = 497); Q2) HPV-negative women from the self-sampling group were asked about their experiences with self-sampling (n = 2366); and Q3) HPV-negative women in the clinician-collection group were asked about their experiences with clinician-based sampling (n = 2092). Response rates ranged from 71.6 to 79.4%. Women reported significantly lower levels of shame, nervousness, discomfort and pain during self-sampling compared to clinician-based sampling. However, trust in correct sampling was significantly higher during clinician-based sampling. The majority of women in group Q1 preferred self-sampling (76.5%) to clinician-based sampling (11.9%) in future screening, while 11.6% of women reported to have no preference for either method. To conclude, women from a regular screening population have a positive attitude towards self-sampling but express some concerns with respect to accuracy. The majority prefers self-sampling to clinician-based sampling in future screening. Based on these results, a screening approach where women can choose for either self-sampling or clinician-based sampling seems highly justifiable.
Databáze: OpenAIRE
Externí odkaz: